How multi-omics and AI-driven target identification can drive the future of personalized medicine

The details and reactions behind a recent FDA investigation into the cancer-risk of CAR-T therapies

A superbug vaccine could protect patients against multiple healthcare-associated infections at once

The Medicine Maker’s all-inclusive advent calendar…

A deep dive into the dangers of fentanyl entering the US supply chain – and the importance of the Drug Supply Chain Security Act

Exploring the ins and outs of a recent UK-based collaboration between two prominent advanced medicine players

Experimental insomnia drug shows promise in alleviating opioid withdrawal symptoms and opioid-seeking behavior

How a three-way collaboration aims to use digital twins to refine the efficiency of adeno-associated virus manufacture

Howard Fillit shares his views on the historical research lag, the slim successes so far, and the target pathways that offer most hope

Researchers genetically modify chickens to build bird-flu resistance – read more here.